Schedule 5 Fees for certificates of registration
| Column 1 | Column 2 | Column 3 | ||||
|---|---|---|---|---|---|---|
| Type of application | Fees for applications in respect of products prepared from not more than 5 homoeopathic stocks | Fees for other applications | ||||
| 1 | An application in respect of a product which is both prepared solely from repeat stocks and is of a repeat formulation. | F1£194 | F2£479 | |||
| 2 | An application in respect of a product which is either— | F3£582 | F4£857 | |||
| (a) | prepared solely from repeat stocks; or | |||||
| (b) | is of a repeat formulation. | |||||
| 3 | A mutual recognition procedure incoming application. | F5£610 | F6£777 | |||
| 4 | A mutual recognition outgoing application (regulatory assistance). | £287 | £374 | |||
| 5 | A decentralised procedure application where the UK is a concerned member State. | F7£524 | F8£686 | |||
| 6 | A decentralised procedure application where the UK is the reference member State. | £813 | £1,063 | |||
| 7 | Any other application. | F9£962 | F10£1,259 | |||
Annotations
Textual amendments
- F1
Sum in Sch. 5 Table Item 1 substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 30(2)(a)(i)
- F2
Sum in Sch. 5 Table Item 1 substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 30(2)(b)(i)
- F3
Sum in Sch. 5 Table Item 2 substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 30(2)(a)(ii)
- F4
Sum in Sch. 5 Table Item 2 substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 30(2)(b)(ii)
- F5
Sum in Sch. 5 Table Item 3 substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 30(2)(a)(iii)
- F6
Sum in Sch. 5 Table Item 3 substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 30(2)(b)(iii)
- F7
Sum in Sch. 5 Table Item 5 substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 30(2)(a)(iv)
- F8
Sum in Sch. 5 Table Item 5 substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 30(2)(b)(iv)
- F9
Sum in Sch. 5 Table Item 7 substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 30(2)(a)(v)
- F10
Sum in Sch. 5 Table Item 7 substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 30(2)(b)(v)